This suggests that an appropriate amount of methyl donors in the diet might be an effective complementary and also preventive therapy, from which pancreatic cancer patients with increased NFkB and IL17 level, as well as healthy people, could benefit to keep their inflammation level under control. Here, NFKB1 is linked to familial pancreatic carcinoma.